<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´   ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ¤ç‰©æ¿€ç´  (Plant hormones, N): ç”±ç‰¹å®šå™¨å®˜æˆ–ç»„ç»‡äº§ç”Ÿï¼Œä½†ä¸å±€é™äºå•ä¸€ç±»å‹ç»†èƒçš„åŒ–å­¦ç‰©è´¨ã€‚å®ƒä»¬çš„ä½œç”¨ä¸ä¸€å®šæ˜¯é•¿è·ç¦»çš„ï¼ˆä¹Ÿå¯ä»¥æ˜¯åŸä½ä½œç”¨ï¼‰ï¼Œå…¶æ•ˆåº”ä¸ä»…å–å†³äºæµ“åº¦ï¼Œè¿˜å–å†³äºé¶æ ‡çš„æ•æ„Ÿæ€§ã€‚ ææ€§è¿è¾“ (Polar transp...">
    <meta name="keywords" content="æ¤ç‰©ç”Ÿç†å­¦/ååŠ, chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´ ">
    <meta name="author" content="Yukari502">
    <meta name="article-slug" content="chapt-111-æ¤ç‰©æ¿€ç´ ç”Ÿé•¿ç´ ">
    <meta name="root-path" content="../../">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-111-æ¤ç‰©æ¿€ç´ ç”Ÿé•¿ç´ .html">
    <meta property="og:title" content="chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´ ">
    <meta property="og:description" content="chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´   ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ¤ç‰©æ¿€ç´  (Plant hormones, N): ç”±ç‰¹å®šå™¨å®˜æˆ–ç»„ç»‡äº§ç”Ÿï¼Œä½†ä¸å±€é™äºå•ä¸€ç±»å‹ç»†èƒçš„åŒ–å­¦ç‰©è´¨ã€‚å®ƒä»¬çš„ä½œç”¨ä¸ä¸€å®šæ˜¯é•¿è·ç¦»çš„ï¼ˆä¹Ÿå¯ä»¥æ˜¯åŸä½ä½œç”¨ï¼‰ï¼Œå…¶æ•ˆåº”ä¸ä»…å–å†³äºæµ“åº¦ï¼Œè¿˜å–å†³äºé¶æ ‡çš„æ•æ„Ÿæ€§ã€‚ ææ€§è¿è¾“ (Polar transp...">
    <meta property="og:site_name" content="Digital Garden">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-111-æ¤ç‰©æ¿€ç´ ç”Ÿé•¿ç´ .html">
    <meta property="twitter:title" content="chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´ ">
    <meta property="twitter:description" content="chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´   ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ¤ç‰©æ¿€ç´  (Plant hormones, N): ç”±ç‰¹å®šå™¨å®˜æˆ–ç»„ç»‡äº§ç”Ÿï¼Œä½†ä¸å±€é™äºå•ä¸€ç±»å‹ç»†èƒçš„åŒ–å­¦ç‰©è´¨ã€‚å®ƒä»¬çš„ä½œç”¨ä¸ä¸€å®šæ˜¯é•¿è·ç¦»çš„ï¼ˆä¹Ÿå¯ä»¥æ˜¯åŸä½ä½œç”¨ï¼‰ï¼Œå…¶æ•ˆåº”ä¸ä»…å–å†³äºæµ“åº¦ï¼Œè¿˜å–å†³äºé¶æ ‡çš„æ•æ„Ÿæ€§ã€‚ ææ€§è¿è¾“ (Polar transp...">

    <title>chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´  - D.RAY</title>

    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap"
        rel="stylesheet">

    <!-- Highlight.js -->
    <link rel="stylesheet"
        href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/styles/atom-one-dark.min.css">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/highlight.min.js"></script>

    <!-- KaTeX -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <!-- Marked.js for Markdown parsing -->
    <script src="https://cdn.jsdelivr.net/npm/marked/marked.min.js"></script>

    <!-- Mermaid.js for diagrams and flowcharts -->
    <script type="module">
        import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
        mermaid.initialize({
            startOnLoad: false,
            theme: 'dark',
            themeVariables: {
                primaryColor: '#8b5cf6',
                primaryTextColor: '#fff',
                primaryBorderColor: '#7c3aed',
                lineColor: '#a78bfa',
                secondaryColor: '#6d28d9',
                tertiaryColor: '#5b21b6'
            }
        });
        window.mermaid = mermaid;
    </script>

    <!-- Custom Styles -->
    <link rel="stylesheet" href="../../style.css">
    <link rel="icon" href="../../ico/favicon.ico" type="image/x-icon">

    <style>
        .article-page {
            max-width: 900px;
            margin: 0 auto;
            padding: 2rem;
        }

        .article-header {
            margin-bottom: 3rem;
            padding-bottom: 2rem;
            border-bottom: 2px solid var(--border-color);
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-meta {
            display: flex;
            gap: 1rem;
            color: var(--text-secondary);
            font-size: 0.95rem;
        }

        .article-meta span {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--accent-color);
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
            transition: transform 0.2s;
        }

        .back-link:hover {
            transform: translateX(-4px);
        }

        .article-content {
            font-size: 1.1rem;
            line-height: 1.8;
        }

        @media (max-width: 768px) {
            .article-page {
                padding: 1rem;
            }

            .article-title {
                font-size: 2rem;
            }
        }

        .article-footer {
            margin-top: 4rem;
            padding-top: 2rem;
            border-top: 1px solid var(--border-color);
            text-align: center;
            color: var(--text-secondary);
            font-size: 0.85rem;
        }

        .article-footer .disclaimer {
            font-size: 0.75rem;
            margin-top: 0.5rem;
            font-style: italic;
            opacity: 0.8;
        }
    </style>
    <meta name="build-hash" content="5427a23a27a2aa9782f86daf4cf7da43">
</head>

<body>
    <div class="article-page">
        <a href="../../" class="back-link">
            <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none"
                stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="19" y1="12" x2="5" y2="12"></line>
                <polyline points="12 19 5 12 12 5"></polyline>
            </svg>
            è¿”å›ä¸»é¡µ
        </a>

        <div class="article-header">
            <h1 class="article-title">chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´ </h1>
            <div class="article-meta">
                <span>ğŸ“… 2026-01-14</span>
                <span>ğŸ“‚ æ¤ç‰©ç”Ÿç†å­¦/ååŠ</span>
            </div>
        </div>

        <article class="article-content markdown-body" id="article-content">
            <!-- Content will be rendered here -->
        </article>

        <!-- Store markdown content in a script tag -->
        <script type="text/markdown" id="markdown-source">
# chapt 11.1 æ¤ç‰©æ¿€ç´ ï¼šç”Ÿé•¿ç´ 

### ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š

**æ¤ç‰©æ¿€ç´  (Plant hormones, N):** ç”±ç‰¹å®šå™¨å®˜æˆ–ç»„ç»‡äº§ç”Ÿï¼Œä½†ä¸å±€é™äºå•ä¸€ç±»å‹ç»†èƒçš„åŒ–å­¦ç‰©è´¨ã€‚å®ƒä»¬çš„ä½œç”¨ä¸ä¸€å®šæ˜¯é•¿è·ç¦»çš„ï¼ˆä¹Ÿå¯ä»¥æ˜¯åŸä½ä½œç”¨ï¼‰ï¼Œå…¶æ•ˆåº”ä¸ä»…å–å†³äºæµ“åº¦ï¼Œè¿˜å–å†³äºé¶æ ‡çš„æ•æ„Ÿæ€§ã€‚

**ææ€§è¿è¾“ (Polar transport, N):** ç”Ÿé•¿ç´ åœ¨æ¤ç‰©ä½“å†…ä¸»è¦ä»å½¢æ€å­¦ä¸Šç«¯å‘å½¢æ€å­¦ä¸‹ç«¯ï¼ˆå‘åŸºéƒ¨ï¼‰è¿›è¡Œçš„å•å‘è¿è¾“è¿‡ç¨‹ã€‚è¿™ç§è¿è¾“ç‹¬ç«‹äºé‡åŠ›æ–¹å‘ã€‚

**åŒ–å­¦æ¸—é€æ¨¡å‹ (Chemiosmotic Model, N):** è§£é‡Šç”Ÿé•¿ç´ ææ€§è¿è¾“æœºåˆ¶çš„æ¨¡å‹ã€‚ä¸»è¦åŒ…æ‹¬ï¼š1. ç»†èƒå£ç”± H+-ATPase ç»´æŒé…¸æ€§ï¼Œä½¿éƒ¨åˆ† IAA å‘ˆè´¨å­åŒ–å½¢å¼ (IAAH)ï¼›2. IAAH è¢«åŠ¨è¿›å…¥æˆ– IAA- é€šè¿‡æ¬¡çº§ä¸»åŠ¨å…±è½¬è¿ (AUX1) è¿›å…¥ç»†èƒï¼›3. èƒè´¨å‘ˆä¸­æ€§ï¼ŒIAA è§£ç¦»ä¸º IAA-ï¼›4. IAA- é€šè¿‡é›†ä¸­åœ¨ç»†èƒåŸºéƒ¨çš„è¾“å‡ºè½½ä½“ (PINs) æµå‡ºç»†èƒã€‚

**é…¸ç”Ÿé•¿å‡è¯´ (Acid growth hypothesis, N):** ç”Ÿé•¿ç´ æ¿€æ´»è´¨è†œ H+-ATPaseï¼Œå¯¼è‡´è´¨å­æ’å‡ºï¼Œä½¿ç»†èƒå£é…¸åŒ–ï¼›é…¸æ€§ç¯å¢ƒæ¿€æ´»ç»†èƒå£æ¾å¼›å› å­ï¼ˆå¦‚æ‰©å¼ è›‹ç™½ expansinï¼‰ï¼Œå¯¼è‡´ç»†èƒå£æ¾å¼›ï¼Œä»è€Œä¿ƒè¿›ç»†èƒä¼¸é•¿ã€‚

**PINè›‹ç™½ (PIN proteins, N):** ç”Ÿé•¿ç´ å¤–æ’è½½ä½“ï¼ˆEfflux carriersï¼‰ï¼Œä»¥ "pin-formed" çªå˜ä½“å‘½åã€‚å®ƒä»¬åœ¨æ¤ç‰©ç»†èƒä¸­å‘ˆä¸å¯¹ç§°åˆ†å¸ƒï¼ˆå¦‚ PIN1 é€šå¸¸åœ¨åŸºéƒ¨ï¼ŒPIN2 åœ¨æ ¹çš®å±‚åŸºéƒ¨/è¡¨çš®é¡¶éƒ¨ï¼‰ï¼Œå…¶ææ€§åˆ†å¸ƒå†³å®šäº†ç”Ÿé•¿ç´ æµåŠ¨çš„æ–¹å‘ã€‚

**TIR1 (Transport Inhibitor Response 1, N):** ç”Ÿé•¿ç´ å—ä½“ï¼Œæ˜¯ SCF æ³›ç´ è¿æ¥é…¶å¤åˆç‰© (SCF^TIR1) çš„ F-box äºšåŸºã€‚å®ƒèƒ½ç‰¹å¼‚æ€§ç»“åˆç”Ÿé•¿ç´ ï¼Œå¹¶ä¿ƒè¿› Aux/IAA é˜»éè›‹ç™½çš„é™è§£ã€‚

**Aux/IAAè›‹ç™½ (Aux/IAA proteins, N):** ä¸€ç±»åŠè¡°æœŸå¾ˆçŸ­çš„æ ¸è›‹ç™½ï¼Œæ˜¯ç”Ÿé•¿ç´ å“åº”åŸºå› çš„é˜»éç‰© (Repressor)ã€‚åœ¨ä½ç”Ÿé•¿ç´ æ°´å¹³ä¸‹ï¼Œå®ƒä»¬æŠ‘åˆ¶ ARF è½¬å½•å› å­çš„æ´»æ€§ï¼›åœ¨é«˜ç”Ÿé•¿ç´ æ°´å¹³ä¸‹ï¼Œè¢« SCF^TIR1 å¤åˆç‰©æ³›ç´ åŒ–å¹¶é™è§£ã€‚

**ARF (Auxin Response Factors, N):** ç”Ÿé•¿ç´ å“åº”å› å­ï¼Œä¸€ç±»ç»“åˆåœ¨ç”Ÿé•¿ç´ å“åº”å…ƒä»¶ (AuxRE) ä¸Šçš„è½¬å½•å› å­ã€‚å®ƒä»¬è°ƒæ§ç”Ÿé•¿ç´ è¯±å¯¼åŸºå› çš„è¡¨è¾¾ã€‚

**ABP1 (Auxin Binding Protein 1, N):** ä¸€ç§ç»†èƒè¡¨é¢ç”Ÿé•¿ç´ å—ä½“ã€‚è™½ç„¶å…¶åŠŸèƒ½æ›¾æœ‰äº‰è®®ï¼Œä½†è¿‘æœŸç ”ç©¶è¡¨æ˜å®ƒä¸ TMK1 æ¿€é…¶å½¢æˆå¤åˆç‰©ï¼Œä»‹å¯¼éè½¬å½•çš„ç»†èƒè¡¨é¢ä¿¡å·ä¼ å¯¼ï¼ˆå¦‚å¿«é€Ÿçš„ç»†èƒå£é…¸åŒ–å’Œç»†èƒéª¨æ¶é‡æ’ï¼‰ã€‚

---

### äºŒã€ æ¤ç‰©ç”Ÿç†å­¦é‡ç‚¹å†…å®¹å½’çº³

**1. ç”Ÿé•¿ç´ çš„å‘ç°å†å²**
*   **Darwin (1880):** å‘ç°èƒšèŠ½é˜å°–ç«¯æ„Ÿå…‰åå‘åŸºéƒ¨ä¼ é€’æŸç§â€œå½±å“â€ï¼Œå¯¼è‡´å‘å…‰æ€§å¼¯æ›²ã€‚
*   **Boysen-Jensen (1913):** è¯æ˜è¿™ç§åˆºæ¿€å¯ä»¥é€šè¿‡ç¼è„‚ä¼ é€’ï¼Œä½†ä¸èƒ½é€šè¿‡äº‘æ¯ç‰‡ï¼Œè¡¨æ˜æ˜¯åŒ–å­¦ç‰©è´¨ã€‚
*   **F. W. Went (1926):** æ”¶é›†è¯¥ç‰©è´¨åˆ°ç¼è„‚å—ä¸­ï¼Œå¹¶å»ºç«‹äº†ç”Ÿç‰©æµ‹å®šæ³• (Bioassay)ï¼Œå‘½åä¸ºâ€œç”Ÿé•¿ç´  (Auxin)â€ã€‚

**2. ç”Ÿç‰©åŒ–å­¦ä»£è°¢**
*   **åˆæˆï¼š** ä¸»è¦åœ¨åˆ†ç”Ÿç»„ç»‡ã€å«©å¶åŠå‘è‚²ä¸­çš„æœå®ç§å­ä¸­åˆæˆã€‚å­˜åœ¨è‰²æ°¨é…¸ä¾èµ–é€”å¾„ï¼ˆIPA, TAM, IAN é€”å¾„ï¼‰å’Œè‰²æ°¨é…¸éä¾èµ–é€”å¾„ã€‚
*   **ç»“åˆä¸é™è§£ï¼š** 90%ä»¥ä¸Šçš„ IAA ä»¥ç»“åˆæ€ï¼ˆå¦‚ IAA-æ°¨åŸºé…¸ï¼ŒIAA-ç³–ï¼‰å­˜åœ¨ï¼Œç”¨äºå‚¨å­˜æˆ–è§£æ¯’ã€‚é™è§£é€”å¾„åŒ…æ‹¬è„±ç¾§ï¼ˆè¿‡æ°§åŒ–ç‰©é…¶ï¼‰å’Œéè„±ç¾§é€”å¾„ã€‚

**3. è¿è¾“æœºåˆ¶**
*   **ææ€§è¿è¾“ï¼š** ä¾èµ–äº **åŒ–å­¦æ¸—é€æ¨¡å‹**ã€‚æ ¸å¿ƒåœ¨äº **PIN è›‹ç™½** çš„ä¸å¯¹ç§°å®šä½ï¼ˆAsymmetric localizationï¼‰å»ºç«‹ç”Ÿé•¿ç´ æ¢¯åº¦ã€‚
*   **è½¬è¿è›‹ç™½ï¼š**
    *   **AUX1/LAX:** å†…æµè½½ä½“ (Influx carrier)ã€‚
    *   **PINs:** å¤–æµè½½ä½“ (Efflux carrier)ï¼Œå…·æœ‰åŠ¨æ€å¾ªç¯ (Cycling) ç‰¹æ€§ã€‚
    *   **ABCB/PGP:** ATPç»“åˆç›’è½¬è¿è›‹ç™½ï¼Œè¾…åŠ©ç”Ÿé•¿ç´ è¿è¾“ã€‚

**4. ç”Ÿç†åŠŸèƒ½**
*   ä¿ƒè¿› **ç»†èƒä¼¸é•¿**ï¼ˆæœºåˆ¶ï¼šé…¸ç”Ÿé•¿å‡è¯´ï¼‰ã€‚
*   è°ƒæ§ **å‘æ€§è¿åŠ¨**ï¼ˆå¦‚å‘é‡åŠ›æ€§ï¼šæ ¹å† æ„Ÿé‡ -> ç”Ÿé•¿ç´ é‡åˆ†å¸ƒ -> PIN2 ä»‹å¯¼ä¸å¯¹ç§°æµåŠ¨ -> å·®å¼‚ç”Ÿé•¿ï¼‰ã€‚
*   å‘è‚²æ•ˆåº”ï¼šé¡¶ç«¯ä¼˜åŠ¿ã€ç”Ÿæ ¹ã€æœå®å‘è‚²ã€ç»´ç®¡æŸåˆ†åŒ–ç­‰ã€‚

**5. ä¿¡å·è½¬å¯¼ (Signaling)**
*   **ç»å…¸æ ¸ä¿¡å·é€šè·¯ï¼š** ç”Ÿé•¿ç´ å……å½“â€œåˆ†å­èƒ¶æ°´â€ï¼Œä¿ƒè¿›å—ä½“ **TIR1** ä¸é˜»éè›‹ç™½ **Aux/IAA** ç»“åˆ -> Aux/IAA è¢« **SCF** å¤åˆç‰©æ³›ç´ åŒ–å¹¶é€šè¿‡ 26S è›‹ç™½é…¶ä½“é™è§£ -> é‡Šæ”¾ **ARF** è½¬å½•å› å­ -> å¯åŠ¨åŸºå› è¡¨è¾¾ã€‚
*   **æœ€æ–°èŒƒå¼ä¿®æ­£ (2025):**
    *   **cAMP ä½œä¸ºç¬¬äºŒä¿¡ä½¿ï¼š** TIR1 å…·æœ‰è…ºè‹·é…¸ç¯åŒ–é…¶ (AC) æ´»æ€§ï¼Œäº§ç”Ÿçš„ cAMP å¯¹äº Aux/IAA-ARF å¤åˆç‰©è§£ç¦»å’Œè½¬å½•æ¿€æ´»æ˜¯å¿…éœ€çš„ã€‚
    *   **ç»†èƒè¡¨é¢ä¿¡å·ï¼š** **ABP1-TMK1** å¤åˆç‰©åœ¨ç»†èƒè¡¨é¢æ„ŸçŸ¥ç”Ÿé•¿ç´ ï¼Œé€šè¿‡ç£·é…¸åŒ–çº§è”ååº”ï¼ˆå¦‚ç£·é…¸åŒ– PIN2ï¼‰è°ƒæ§å¿«é€Ÿååº”ï¼ˆå¦‚æ ¹å‘é‡åŠ›æ€§ï¼‰ï¼Œç‹¬ç«‹äºè½¬å½•é€”å¾„ã€‚

---

### ä¸‰ã€ é‡ç‚¹å®éªŒæ¦‚è¿°

**1. ç‡•éº¦èƒšèŠ½é˜å¼¯æ›²å®éªŒ (Coleoptile Bending Bioassay)**
*   **å®éªŒè€…ï¼š** F. W. Went (1926)
*   **å†…å®¹ï¼š** å°†åˆ‡ä¸‹çš„èƒšèŠ½é˜å°–ç«¯æ”¾ç½®åœ¨ç¼è„‚å—ä¸Šï¼Œè®©ç‰©è´¨æ‰©æ•£ã€‚ç„¶åå°†å¤„ç†è¿‡çš„ç¼è„‚å—ä¸å¯¹ç§°åœ°æ”¾ç½®åœ¨å»å°–ç«¯çš„èƒšèŠ½é˜ä¸€ä¾§ã€‚
*   **ç»“æœï¼š** åœ¨é»‘æš—ä¸­ï¼ŒèƒšèŠ½é˜å‘æœªæ”¾ç½®ç¼è„‚å—çš„ä¸€ä¾§å¼¯æ›²ã€‚å¼¯æ›²çš„è§’åº¦ä¸ç¼è„‚å—ä¸­ç”Ÿé•¿ç´ çš„é‡æˆæ­£æ¯”ã€‚
*   **ç»“è®ºï¼š** è¯å®äº†ç”Ÿé•¿ç´ çš„ç‰©è´¨æ€§ï¼Œå¹¶å»ºç«‹äº†å®šé‡åˆ†æç”Ÿé•¿ç´ çš„æ–¹æ³•ã€‚

**2. PIN è›‹ç™½å®šä½ä¸åŠŸèƒ½å®éªŒ**
*   **å†…å®¹ï¼š** ä½¿ç”¨å…ç–«è§å…‰æˆ– GFP æ ‡è®°è§‚å¯Ÿ PIN è›‹ç™½åœ¨æ‹Ÿå—èŠ¥æ ¹éƒ¨çš„åˆ†å¸ƒï¼Œå¹¶ç»“åˆ *pin* çªå˜ä½“è¡¨å‹åˆ†æã€‚
*   **ç»“æœï¼š** PIN1 å®šä½åœ¨ç»´ç®¡æŸç»†èƒåŸºéƒ¨ï¼ˆè´Ÿè´£å‘åŸºè¿è¾“ï¼‰ï¼›PIN2 å®šä½åœ¨çš®å±‚ç»†èƒåŸºéƒ¨å’Œè¡¨çš®ç»†èƒé¡¶éƒ¨ï¼ˆè´Ÿè´£é‡åŠ›å“åº”ä¸­çš„ä¾§å‘è¿è¾“ï¼‰ã€‚
*   **ç»“è®ºï¼š** PIN è›‹ç™½çš„ä¸å¯¹ç§°åˆ†å¸ƒå†³å®šäº†ç”Ÿé•¿ç´ æµåŠ¨çš„ææ€§ï¼Œå¯¹èƒšèƒå‘è‚²å’Œå‘é‡åŠ›æ€§è‡³å…³é‡è¦ã€‚

**3. TIR1 å—ä½“ç»“åˆå®éªŒ**
*   **å†…å®¹ï¼š** æµ‹è¯•æ”¾å°„æ€§æ ‡è®°çš„ IAA æ˜¯å¦èƒ½ç»“åˆ SCF^TIR1 å¤åˆç‰©ï¼Œå¹¶åŠ å…¥ç«äº‰å‰‚ã€‚
*   **ç»“æœï¼š** æ´»æ€§ç”Ÿé•¿ç´ ï¼ˆIAA, NAA, 2,4-Dï¼‰èƒ½ç«äº‰æ€§ç»“åˆï¼Œè€Œæ— æ´»æ€§ç±»ä¼¼ç‰©ï¼ˆè‹¯ç”²é…¸ï¼‰æˆ–å‰ä½“ï¼ˆè‰²æ°¨é…¸ï¼‰ä¸èƒ½ã€‚
*   **ç»“è®ºï¼š** è¯æ˜ TIR1 æ˜¯çœŸæ­£çš„ç”Ÿé•¿ç´ å—ä½“ã€‚

---

### å››ã€ é—®é¢˜å›ç­” (Q&A)

ææ–™ä¸­ç©¿æ’äº†ä¸€äº›æ€è€ƒé¢˜ï¼ˆHomework/Questionsï¼‰ï¼ŒåŸºäºä¸“å®¶çŸ¥è¯†åŠææ–™å›ç­”å¦‚ä¸‹ï¼š

**Q1: How to generate auxin (IAA) deficient mutant? Has anyone succeeded? Why (not)? (å¦‚ä½•äº§ç”Ÿç”Ÿé•¿ç´ ç¼ºå¤±çªå˜ä½“ï¼Ÿæœ‰äººæˆåŠŸäº†å—ï¼Ÿä¸ºä»€ä¹ˆï¼Ÿ)**
*   **Answer:** æéš¾è·å¾—å®Œå…¨ç¼ºå¤±ç”Ÿé•¿ç´ çš„çªå˜ä½“ã€‚
    *   **åŸå›  1 (Redundancy):** ç”Ÿé•¿ç´ åˆæˆå­˜åœ¨å¤šæ¡é€”å¾„ï¼ˆè‰²æ°¨é…¸ä¾èµ–åŠéä¾èµ–ï¼‰ï¼Œä¸”åŸºå› å®¶æ—æˆå‘˜ä¼—å¤šï¼ˆåŠŸèƒ½å†—ä½™ï¼‰ï¼Œå•ä¸€åŸºå› çªå˜ä¸è¶³ä»¥æ¶ˆé™¤æ‰€æœ‰ IAAã€‚
    *   **åŸå›  2 (Lethality):** ç”Ÿé•¿ç´ å¯¹æ¤ç‰©èƒšèƒå‘è‚²å’ŒåŸºæœ¬ç”Ÿå­˜è‡³å…³é‡è¦ï¼Œå®Œå…¨ç¼ºå¤±é€šå¸¸å¯¼è‡´èƒšèƒè‡´æ­» (Lethal)ã€‚

**Q2: How to prove or disprove the chemiosmotic model of auxin polar transport? (å¦‚ä½•è¯æ˜æˆ–è¯ä¼ªç”Ÿé•¿ç´ ææ€§è¿è¾“çš„åŒ–å­¦æ¸—é€æ¨¡å‹ï¼Ÿ)**
*   **Answer:**
    1.  **pH ä¾èµ–æ€§ï¼š** éªŒè¯ç¢±æ€§æˆ–ä¸­æ€§ç¼“å†²æ¶²æ˜¯å¦ä¼šé˜»æ­¢ç”Ÿé•¿ç´ çš„è¢«åŠ¨å¸æ”¶ï¼ˆæ¨¡å‹é¢„æµ‹é…¸æ€§ç¯å¢ƒåˆ©äº IAAH è¿›å…¥ï¼‰ã€‚
    2.  **è½¬è¿è›‹ç™½ï¼š** å¯»æ‰¾æ˜¯å¦å­˜åœ¨ç‰¹å¼‚æ€§å‘å¤–è½¬è¿ IAA ä¸”ä»…å®šä½äºç»†èƒä¸€ä¾§çš„è›‹ç™½è´¨ï¼ˆå³åæ¥å‘ç°çš„ PINsï¼‰ã€‚

**Q3: What should we do after knowing the polar localization of PINs? What are nexts? (çŸ¥é“ PIN çš„ææ€§å®šä½åè¯¥åšä»€ä¹ˆï¼Ÿ)**
*   **Answer:** ç ”ç©¶ PIN è›‹ç™½ææ€§æ˜¯å¦‚ä½•å»ºç«‹å’Œç»´æŒçš„ï¼ˆå¦‚å›Šæ³¡è¿è¾“ã€å†…åå¾ªç¯ Endocytic cyclingï¼‰ï¼›ç ”ç©¶ç»†èƒéª¨æ¶ï¼ˆå¾®ä¸ï¼‰åœ¨å…¶ä¸­çš„ä½œç”¨ï¼›ä»¥åŠä¿¡å·ï¼ˆå¦‚ç”Ÿé•¿ç´ è‡ªèº«ã€GNOM è›‹ç™½ï¼‰å¦‚ä½•è°ƒèŠ‚ PIN çš„å®šä½åŠ¨æ€ã€‚

**Q4: How auxin binds to its receptors? How a receptor is "activated"? (ç”Ÿé•¿ç´ å¦‚ä½•ç»“åˆå—ä½“ï¼Ÿå—ä½“å¦‚ä½•è¢«â€œæ¿€æ´»â€ï¼Ÿ)**
*   **Answer:** ç”Ÿé•¿ç´ ä½œä¸ºâ€œåˆ†å­èƒ¶æ°´ (Molecular glue)â€ï¼Œç»“åˆåœ¨ TIR1 çš„å£è¢‹ä¸­ï¼Œå¢å¼º TIR1 ä¸ Aux/IAA è›‹ç™½çš„äº²å’ŒåŠ›ã€‚ä¸¥æ ¼æ¥è¯´ï¼ŒTIR1 ä¸æ˜¯é€šè¿‡æ„è±¡æ”¹å˜è¢«â€œæ¿€æ´»â€ï¼Œè€Œæ˜¯é€šè¿‡ç»“åˆç”Ÿé•¿ç´ æ¥æ‹›å‹Ÿåº•ç‰©ï¼ˆAux/IAAï¼‰è¿›å…¥æ³›ç´ åŒ–é™è§£ç¨‹åºã€‚
    *   *æ³¨ï¼šæœ€æ–° 2025 ç ”ç©¶è¡¥å……æŒ‡å‡º TIR1 ç»“åˆç”Ÿé•¿ç´ åè¿˜æ¿€æ´»äº†å…¶è…ºè‹·é…¸ç¯åŒ–é…¶æ´»æ€§äº§ç”Ÿ cAMPã€‚*

        </script>

        <footer class="article-footer">
            <p>&copy; 2025 Yukari502. All rights reserved.</p>
            <p class="disclaimer">Disclaimer: Portions of this content may be generated by AI. Please exercise
                discretion and verify information independently.</p>
        </footer>
    </div>

    <script src="../../script.js"></script>
</body>

</html>